Add BrightSurf on Google Email

Molecular imaging improves care for children with brain cancer

A new molecular imaging technique, F-18 FET, has been shown to be highly effective in detecting and differentiating brain lesions in children, with an accuracy rate of 94%. This study improves the clinical management of pediatric brain cancer patients by providing more accurate information about tumor progression and treatment.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 10, 2013

Immune system to fight brain tumors

Researchers at Lund University have developed a vaccine-based treatment that stimulates the immune system to fight brain tumors, with promising results in animal experiments. The treatment has shown significant effectiveness in curing rats of their brain tumors.

SourceLund University·JournalJournal of Neuroimmunology·DateMay 30, 2013

Virus-like particles provide vital clues about brain tumors

Researchers at Lund University have discovered that exosome molecular profiles reflect the aggressiveness of brain tumours, offering a new approach for diagnosis and treatment. The study's findings suggest that exosomes could serve as biomarkers to guide patient care and monitor treatment response.

SourceLund University·JournalProceedings of the National Academy of Sciences·DateApr 17, 2013

Using fat to fight brain cancer

Johns Hopkins researchers have discovered that mesenchymal stem cells derived from human adipose tissue can seek out and destroy glioblastoma cancer cells in the brain. This innovative approach may provide a new tool for accessing difficult-to-reach areas of the brain where cancer cells proliferate.

SourceJohns Hopkins Medicine·JournalPLOS ONE·DateMar 12, 2013

Compound stimulates tumor-fighting protein in cancer therapy

Researchers identified a compound called TIC10 that stimulates the tumor suppression capabilities of TRAIL, inducing cancer cell death in mice. The compound is effective in cancer cell samples and cell lines resistant to conventional therapies, showing promise as a new treatment option for advanced cancer.

SourcePenn State·JournalScience Translational Medicine·DateFeb 6, 2013

Forecasting brain tumors like a storm

Researchers developed a new method to predict individual patient's brain tumor growth, enabling physicians to rapidly identify effective therapies. The approach accounts for tumor features such as shape, density, and growth rate, allowing clinicians to distinguish between patients with different tumor characteristics.

SourceNorthwestern University·JournalPLOS ONE·DateJan 23, 2013

'Navigating Life with a Brain Tumor'

The new book, Navigating Life with a Brain Tumor, offers comprehensive guidance on managing brain tumors, including treatment options, side effects, and coping strategies. Written by neuro-oncologists from Mayo Clinic and Tufts Medical Center, the book aims to empower patients to be active participants in their care.

Smaller radiation fields can spare brain when treating tumors, Wake Forest Baptist research finds

Researchers from Wake Forest Baptist Medical Center found that smaller radiation fields can be safely used to treat glioblastoma patients without compromising treatment efficacy. This study suggests that focusing radiation on smaller areas of the brain may help preserve cognition and reduce symptoms associated with radiation toxicity.

SourceAtrium Health Wake Forest Baptist·JournalAmerican Journal of Clinical Oncology·DateJan 9, 2013

Harnessing the ID in glioma

Researchers found ID proteins essential for retaining glioma-initiating cells in a specific extracellular niche, maintaining their cancer-promoting properties. The study's results suggest ID proteins as potential therapeutic targets for glioma treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 17, 2012

Duke Medicine News new immune therapy successfully treats brain tumors in mice

Researchers at Duke Medicine have developed an artificial protein that stimulates the body's natural immune system to fight cancer. In a study published in the Proceedings of the National Academy of Sciences, the therapy was shown to cure brain tumors in six out of eight mice, with no harm to surrounding normal tissue.

SourceDuke University Medical Center·JournalProceedings of the National Academy of Sciences·DateDec 17, 2012

Pitt Cancer Institute finds new targets for drugs to defeat aggressive brain tumor

Pitt Cancer Institute researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line that could offer new hope for drug treatment to destroy cancer cells. The findings may lead to the development of adjuvant chemotherapy drugs that will improve patient survival rates.

SourceUniversity of Pittsburgh Schools of the Health Sciences·JournalMolecular Cancer Research·DateDec 14, 2012

For brain tumors, origins matter

Sanford-Burnham researchers found that different brain tumor cell types respond to distinct treatments due to varying growth factor regulation. This discovery offers potential for more effective and less harmful treatments tailored to individual tumors.

SourceSanford Burnham Prebys·JournalOncogene·DateNov 13, 2012